A study confirms the concerns raised in the public domain about how young people’s decreased fitness may affect their future work ability. The association of low youth cardiorespiratory fitness and adulthood decreased work ability persisted until the end of working life, which predicts substantial societal costs. Read Full Article (External Site) Dr. David LowemannDr. David […]
Published on April 8, 2024
Supernus Pharmaceuticals said on Monday the U.S. FDA declined to approve its drug-device combination to treat movement-related symptoms of Parkinson’s disease, sending its shares down 9% in early trade. This is the second time the regulator has refused to approve, dealing a… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is […]
Published on April 8, 2024
Synchron Inc, a rival to Elon Musk’s Neuralink brain implant startup, is preparing to recruit patients for a large-scale clinical trial required to seek commercial approval for its device, the company’s chief executive told Reuters. Synchron on Monday plans to launch an… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is […]
Published on April 8, 2024